fda semaglutide news The obesity drug (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of data showed. Added FDA moves to stop compounding

[15] Potential GLP-1 Interactions According to research published by Liu and colleagues in 2014, green tea extract significantly increased glucagon-like peptide 1 (GLP-1) levels in patients with type 2 diabetes and lipid abnormalities, but only in the within-group comparison

The problem is what the studies actually show

In a systematic review and network meta-analysis, reductions in HbA1c with once-weekly semaglutide 1 mg were numerically greater than with orally administered semaglutide 14 mg, while the efficacy in weight loss was nearly identical

9 (Suppl 1), 2946 (2015)

A mixed model for repeated measurements was used to input any missing data from test subjects that discontinued treatment or required a dose of rescue medication